amyloid beta oligomers (University of California Davis)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameamyloid beta oligomers (University of California Davis)
Drug Alias NameLRL-22 analogsLRL-22LAS-0419LRL-50
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > OligonucleotideDiagnostic agent (In vivo)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of California Davis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of California Davis
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A